[1] ISEZUO S A. The metabolic syndrome:Review of current concepts[J]. Niger Postgrad Med J, 2006, 13(3):247-255. [2] ASTRUP A, DYERBERG J, SELLECK M, et al. Nutrition transition and its relationship to the development of obesity and related chronic diseases[J]. Obes Rev, 2008, 9(suppl 1):48-52. [3] MISRA A, KHURANA L. Obesity and the metabolic syndrome in developing countries[J]. J Clin Endocrinol Metab, 2008, 93(Suppl 1):S9-S30. [4] GAO Y, SONG G Y, ZHOU Y, et al. Vasodilation reduction and insulin resistance in rats induced by high sucrose, high saturated fatty acid and high unsaturated fatty acid diets[J]. Basic & Clinical Medicine, 2006, 26(3):275-279. 高宇, 宋光耀, 周宇, 等. 高糖、高脂饮食诱导大鼠胰岛素抵抗和血管舒张功能减弱[J]. 基础医学与临床, 2006, 26(3):275-279. [5] HWANG I S, HO H, HOFFMAN B B, et al. Fructose-induced insulin resistance and hypertension in rats[J]. Hypertension, 1987, 10(5):512-516. [6] DEKKER M J, SU Q Z, BAKER C, et al. Fructose:a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome[J]. Am J Physiol Endocrinol Metab, 2010, 299(5):E685-E694. [7] YANG Y X, WANG L L, WANG S M, et al. An integrated metabonomic approach to studing metabolic profiles in rat models with insulin resistance induced by high fructose[J]. Mol Biosyst, 2015, 10(7):1803-1811. [8] SI D H, CHEN L Y. Drug treatment of insulin resistance[J]. China Pharmacist, 2005, 8(7):70-72. 史道华, 陈鹭颖. 胰岛素抵抗的药物治疗[J]. 中国药师, 2005, 8(7):70-72. [9] LIU H Q, ZHONG L J, JI B P, et al. Drug treatment of insulin resistance[J]. China Pharmaceuticals, 2005, 14(1):77-78. 刘洪庆, 仲丽军, 纪宝平, 等. 胰岛素抵抗的药物治疗[J]. 中国药业, 2005, 14(1):77-78. [10] 王琳琳. 黄连解毒汤改善胰岛素抵抗的代谢组学研究[D]. 广州:广东药学院, 2015. [11] ZHU Z Z, XIONG M Q, LIN A Z, et al. Effect of Sanhuang Jiangtang (三黄降糖) recipe on insulin peripheral resistance in type Ⅱ diabetes mellitus[J]. Chinese Journal of Integrated Traditional and Western Medicine, 1999, 5(1):36-40. [12] ZOU W J, BAI H Y, GAO X P. The influence of P thomsonii Benth on insulin resistance induced by dexamethasone[J]. Chinese Pharmacological Bulletin, 2004, 20(6):715-716. 邹文俊, 白红艳, 高小平. 中药葛根改善胰岛素抵抗作用的实验研究[J]. 中国药理学通报, 2004, 20(6):715-716. [13] JIN L, AN W C, AN W D. Treatment of 120 cases of diabetes with Gegen Qinlian Decoction[J]. Journal of Changchun University of Traditional Chinese Medicine, 2012, 28(2):315. 金莉, 安文灿, 安文铎. 葛根芩连汤治疗糖尿病120例[J]. 长春中医药大学学报, 2012, 28(2):315. [14] LI Y M, FAN X M, WANG Y M, et al. Therapeutic effects of Gegen Qinlian decoction and its mechanism of action on type 2 diabetic rats[J]. Acta Pharmaceutica Sinica, 2013, 48(9):1415-1421. 李颖萌, 范雪梅, 王义明, 等. 葛根芩连汤对2型糖尿病大鼠的治疗作用及其机制探讨[J]. 药学学报, 2013, 48(9):1415-1421. [15] PAN J Q, XIAO L Y, HAN C, et al. Effects of Gegenqinlian Decoction on antagonizing impaired glucose tolerance in D-galactose-induced rats[J]. Guangdong Pharmaceutical Journal, 2004, 14(1):31-33. 潘竞锵, 肖柳英, 韩超, 等. 葛根芩连汤拮抗D-半乳糖诱导大鼠糖耐量减退作用[J]. 广东药学, 2004, 14(1):31-33. [16] PAN J Q, HAN C, LIU H C, et al. Experimental study on Hypoglycemic effects of Gegenqinliantang (GGQLT)[J]. Chinese New Drugs Journal, 2000, 9(3):167-170. 潘竞锵, 韩超, 刘惠纯, 等. 葛根芩连汤降血糖作用的实验研究[J]. 中国新药杂志, 2000, 9(3):167-170. [17] LPCI K, ALTINTOPRAK N, MULUK N B, et al. The possible mechanisms of the human microbiome in allergic diseases[J]. Eur Arch Otorhinolaryngol, 2012, 274(2):617-626. [18] WANG Z N, KLIPFELL E, BENNETT B J, et al. Gut flora metabolism of phosphatidylcholing promotes cardiovascular disease[J]. Nat ure, 2011, 472(7341):57-63. [19] CLEMENTE J C, URSELL L K, PARFREY L W, et al. The impact of the gut microbiota on human health:an integrative view[J]. Cell, 2012, 148(6):1258-70. [20] CANI P D, AMAR J, IGLESIAS M A, et al. Metabolic endotoxemia initiates obesity and insulin resistance[J]. Diabetes, 2007, 56(7):1761-72. [21] TILG H, KASER A. Gut microbiome, obesity, and metabolic dysfunction[J]. J Clin Invest, 2011, 121(6):2126-2132. [22] CARICILLI A M, SAAD M J. Gut microbiota composition and its effects on obesity and insulin resistance[J]. Curr Opin Clin Nutr Metab Care, 2014, 17(4):312-318. [23] FENG X G, YAN Y Z, ZENG Y P, et al. The effect of Gegen Qinlian Decoction on intestinal flora in damp-heat syndrome of type 2 diabetes[J]. World Journal of Integrated Traditional and Western Medicine, 2016, 11(8):1110-1112. 冯新格, 严育忠, 曾艺鹏, 等. 葛根芩连汤对2型糖尿病湿热证肠道菌群的影响[J]. 世界中西医结合杂志, 2016, 11(8):1110-1112. [24] ZENG Y P, FENG X G, GU C Y, et al. Effect of intestinal flora of type 2 diabetes patients with dampness-heat syndrome treated with Gegen Qinlian Decoction[J]. Hebei Medicine, 2016, 22(10):1731-1734. 曾艺鹏, 冯新格, 谷成英, 等. 葛根芩连汤治疗对2型糖尿病湿热证肠道菌群影响[J]. 河北医学, 2016, 22(10):1731-1734. [25] XU J, LIAN F M, ZHAO L H, et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula[J]. ISME J, 2015, 9(3):552-562. [26] GUO Y, ZHANG Y C, HUANG W H, et al. Dose-response effect of berberine on bile acid profile and gut microbiota in mice[J]. BMC Complement Altern Med, 2016, 16(1):394. [27] NOH K, KANG Y, NEPAL M R, et al. Role of intestinal microbiota in baicalin-induced drug interaction and its Pharmacokinetics[J]. Molecules, 2016, 21(3):337. [28] AKAO T. Differences in the metabolism of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by human intes tinal flora[J]. Biol Pharm Bull, 2000, 23(12):1418-1423. [29] CHAO J, HUO T I, CHENG H Y, et al. Gallic acid ameliorated impaired giucose and lipid homeostasis in high fat diet -induced NAFLD mice[J]. PloS One, 2014, 9(2):e96969. [30] PAN S N, CHEN A L, HAN Z H, et al. 1H NMR-based metabonomic study on the effects of Epimedium on glucocorticoid-induced osteoporosis[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2016, 1038:118-126. [31] ZHANG A H, SUN H, WANG Z G, et al. Metabolomics:towards understanding traditional Chinese medicine[J]. Planta Med, 2010, 76(17):2026-2035. [32] WANG X J, SUN H, ZHANG A H, et al. Potential role of metabolomics apporoaches in the area of traditional Chinese medicine:as pillars of the bridge between Chinese and western medicine[J]. J Pharm Biomed Anal, 2011, 55(5):859-868. [33] MAHMOUD M F, EI-NAGAR M, EI-BASSOSSY H M. Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats[J]. Arch Pharm Res, 2012, 35(1):155-162. [34] ZHANG Y F, YUAN J, ZHANG Y Z, et al. LC-MS/MS analysis of Gegen Qinlian Decoction and its pharmacokinetics after oral administration to rats[J]. Biomed Chromatogr, 2015, 29(4):485-495. [35] HAN Z H, WANG Y L, WANG S M, et al. Effects of Gegen Qinlian decoction on plasma metabonomic profile in insulin resistance rats based on1H NMR metabonomics[J]. Journal of Guangdong Pharmaceutical University, 2015, 31(6):786-790. 韩智慧, 王亚玲, 王淑美, 等. 基于1H NMR代谢组学方法研究葛根芩连汤对IR大鼠模型血浆代谢组的影响[J]. 广东药学院学报, 2015, 31(6):786-790. [36] ZHANG C H, XU G L, LIU Y H, et al. Anti-diabetic activities of Gegen Qinlian Decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T3-L1 adipocytes[J]. Phytomedicine, 2013, 20(3/4):221-229. [37] WANG Z L, XIAO P Y, QI T Z. Hypoglycemic effect of Gegen Qinlian Decoction on type 2 diabetes rats[J]. China Pharmacy, 2014, 25(23):2131-2133. [38] BARHAM D, TRINDER P. An improved colour reagent for the determination of blood glucose by the oxidase system[J]. Analyst, 1972, 97(151):142-145. [39] MATTHEWS D R, HOSKER J P, RUDENSKI A S, et al. Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985, 28(7):412-419. [40] LE GALL G, NOOR S O, RIDGWAY K, et al. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome[J]. J Proteome Res, 2011, 10(9):4208-4218. [41] SHI X H, XIAO C N, WANG Y L, et al. Gallic acid intake induced alterations to systems metabolism in rats[J]. J Proteome Res, 2013, 12(2):991-1006. [42] ZHAO Y, WU J F, LI J V, et al. Gut microbiota composition modifies fecal metabolic profiles in mice[J]. J Proteome Res, 2013, 12(6):2987-2999. [43] MANSOR L S, MEHTA K, AKSENTIJEVIC D, et al. Increased oxidative metabolism following hypoxia in the type 2 diabetic heart, despite normal hypoxia signalling and metabolic adaptation[J]. J Physiol, 2016, 594(2):307-320. [44] DE VADDER F, KOVATCHEVA-DATCHARY P, ZITOUN C, et al. Microbiota-Produced succinate improves glucose homeostasis via intestinal gluconeogenesis[J]. Cell Metab, 2012, 24(1):151-157. [45] CLAYTON T A, LINDON J C, EVERETT J R, et al. An hypothesis for a mechanism underlying hepatotoxin-induced hypercreatinuria[J]. Arch Toxicol, 2003, 77(4):208-217. [46] WATERFIELD C J, TURTON J A, SCALES M D, et al. Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats[J]. Arch Toxicol, 1993, 67(4):244-254. [47] RIBEIRO R A, BONFLEUR M L, AMARAL A G, et al. Taurine supplementation enhances nutrient-induced insulin secretion in pancreatic mice islets[J]. Diabetes Metab Res Rev, 2009, 25(4):370-379. [48] CHUNG S T, HSIA D S, CHACKO S K, et al. Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes[J]. Diabetologia, 2015, 58(3):596-603. [49] DOLARA P, CADERNI G, SALVADORI M, et al. Fecal levels of short-chain fatty acids and bile acids as determinants of colonic mucosal cell proliferation in humans[J]. Nutr Cancer, 2002, 42(2):186-190. [50] ANDOH A, TSUJIKAWA T, FUJIYAMA Y. Role of dietary fiber and short -chain fatty acids in the colon[J]. Current Pharmaceutical Design, 2003, 9(4):347-358. [51] CHEN Y, CAO Y S, LIU X H. Short chain fatty acids and intestinal microflora[J]. Jiangxi Science, 2006, 24(1):38-39. 陈燕, 曹郁生, 刘晓华. 短链脂肪酸与肠道菌群[J]. 江西科学, 2006, 24(1):38-39. [52] WU M M, XIAO H, REN W K, et al. An NMR-based metabolomic approach to investigate the effects of supplementation with glutamic acid in piglets challenged with deoxynivalenol[J]. PLoS One, 2014, 9(12):e113687. [53] BURRIN D G, STOLL B. Metabolic fate and function of dietary glutamate in the gut[J]. Am J Clin Nutr, 2009, 90(3):850S-856S. |